Stereotypic Behaviors and Feeding Difficulties in Adults With Developmental Disabilities (NCT06920615) | Clinical Trial Compass
RecruitingNot Applicable
Stereotypic Behaviors and Feeding Difficulties in Adults With Developmental Disabilities
Norway8 participantsStarted 2025-04-08
Plain-language summary
Adults with developmental disabilities (DD) and autism represent a vulnerable demographic that transitions into adulthood with diverse etiologies, exhibiting a significantly higher prevalence of various challenging behaviors. These problematic behaviors can lead to adverse health outcomes and a diminished quality of life. Addressing these issues often necessitates an interdisciplinary approach to continuity of care, focusing on enhancing functional skills, empowerment, and independence, as well as preventing and mitigating challenging behaviors. The current research proposal comprises of three studies designed to evaluate the efficacy of behavioral interventions for problematic behaviors in adults with DD and autism. If left unaddressed, these behaviors may worsen over time, potentially hindering community involvement, educational opportunities, and employment prospects. These include harmful stereotypies and feeding difficulties.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants will be recruited through referrals at the Department of Neurohabilitation, or from other hospitals in the Oslo Region.
* be 18 years or older,
* have a DD, autism spectrum disorder or a PDD-NOS diagnosis
* and be referred to the specialist habilitation service for adults.
Exclusion Criteria:
* If there are medical causes of the participant's behavioral problem or
* a reasonable possibility that the referred problem is caused by medical variables
* if the client participant receives communal care services and if those are not in accordance with Norwegian standards of services for individuals with DD.
* This could include inappropriate staff-to-client ratio,
* lack of stimulating activities,
* or if on-site training is insufficient.
* the exclusion criteria do not exclude health care from The Oslo University Hospital.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Frequency recording
Timeframe: Each experimental phase will last until there is a stable-state performance of the target behavior, typically within 4-8 weeks.